Sep 7 2010
RevMed ("Revolutions Medical" or the "Company") (OTCBB:RMCP) has secured a binding 5 Year contract to produce 5M syringes/month of its 3mL fixed needle safety syringe with Medical Investment Group, LLC (MIG). MIG, a Massachusetts Limited Liability Company, will fulfill this obligation through its relationship with an internationally certified global medical device manufacturer. The manufacturer currently ships medical products throughout the world and is compliant with all major international standards including FDA, CE and Health Canada as well as those required in Japan, China and India. The factory is fully ISO compliant for medical device manufacturing and has comprehensive clean rooms, packaging and sterilization facilities. The factory has a current capability to scale up to 20 - 50 million syringes per month if required. First shipments for delivery are currently expected at the end of Q1/2011.
Final Documents will be signed on or before September 17, 2010. More specifics on the factory will also be disclosed at final signing. Rich Theriault, with whom the company has worked with for several years on both the RevVac syringe and the company's proprietary MRI software tools, will be managing this effort. He has a wealth of experience delivering numerous products into the medical device and high technology marketplace.
Rich Theriault states "The selection of this manufacturer with these stated capabilities provides Revolutions Medical with the ability to deliver the highest quality and cost effective product to the marketplace. With the strong performance history of this factory we can be assured of meeting the high demand for the product."